These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34542865)

  • 21. Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals.
    Pfützner A; Forst T; Niemeyer M; Bailey T
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1381-9. PubMed ID: 24921223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [SOLOSTAR study demonstrated high levels of patient satisfaction with the use of the insulin pen SoloStar® in the Czech Republic].
    Edelsberger T; Policar M; Pospíšilová D; Psottová J; Houdová J; Zďarská DJ
    Vnitr Lek; 2014 Sep; 60(9):697-704. PubMed ID: 25294756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens.
    Fischer JS; Edelman SV; Schwartz SL
    J Diabetes Sci Technol; 2008 Nov; 2(6):1157-60. PubMed ID: 19885306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL.
    de la Peña A; Seger M; Soon D; Scott AJ; Reddy SR; Dobbins MA; Brown-Augsburger P; Linnebjerg H
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):69-75. PubMed ID: 27119580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals.
    Klausmann G; Hramiak I; Qvist M; Mikkelsen KH; Guo X
    Patient Prefer Adherence; 2013; 7():285-92. PubMed ID: 23630416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.
    Davis EM; Christensen CM; Nystrom KK; Foral PA; Destache C
    Am J Health Syst Pharm; 2008 Jul; 65(14):1347-57. PubMed ID: 18593681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial experience and evaluation of reusable insulin pen devices among patients with diabetes in emerging countries.
    Tschiedel B; Almeida O; Redfearn J; Flacke F
    Diabetes Ther; 2014 Dec; 5(2):545-55. PubMed ID: 25213801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on the dosing accuracy of commonly used disposable insulin pens.
    Krzywon M; van der Burg T; Fuhr U; Schubert-Zsilavecz M; Abdel-Tawab M
    Diabetes Technol Ther; 2012 Sep; 14(9):804-9. PubMed ID: 22694223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus.
    Peyrot M; Rubin RR
    Curr Med Res Opin; 2008 Aug; 24(8):2413-22. PubMed ID: 18627641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation.
    Joubert M; Haddouche A; Morera J; Rod A; Reznik Y
    Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.
    Eby EL; Boye KS; Lage MJ
    J Med Econ; 2013 Oct; 16(10):1231-7. PubMed ID: 23834480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of the SoloSTAR insulin pen device: design verification and validation.
    Bode A
    Expert Opin Drug Deliv; 2009 Jan; 6(1):103-12. PubMed ID: 19236211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States.
    Thurman JE
    Endocr Pract; 2007 Oct; 13(6):672-8. PubMed ID: 17954427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.